Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alitretinoin versus azathioprine for severe chronic non-hyperkeratotic hand eczema
NL-OMON41737Phase 3Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- May 2016
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in hand dermatitis comparing Alitretinoin with Azathioprine (2 arms). Primary endpoint: Primary efficacy endpoint. Started May 2016; status: active, not recruiting.
02
Drugs
alitretinoinazathioprine
03
Conditions
hand dermatitis
Beyond the preview
Go deeper on NL-OMON41737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41737.